Kura Oncology, Inc. (KURA)
12.65
-0.01
(-0.08%)
USD |
NASDAQ |
Aug 31, 16:00
12.57
-0.08
(-0.63%)
After-Hours: 07:22
Kura Oncology Cash and Short Term Investments (Quarterly) : 519.02M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 519.02M |
| March 31, 2026 | 580.82M |
| December 31, 2025 | 667.24M |
| September 30, 2025 | 549.66M |
| June 30, 2025 | 630.73M |
| March 31, 2025 | 658.19M |
| December 31, 2024 | 727.40M |
| September 30, 2024 | 455.30M |
| June 30, 2024 | 491.52M |
| March 31, 2024 | 527.12M |
| December 31, 2023 | 423.96M |
| September 30, 2023 | 452.59M |
| June 30, 2023 | 476.98M |
| March 31, 2023 | 405.90M |
| December 31, 2022 | 437.98M |
| September 30, 2022 | 427.78M |
| June 30, 2022 | 450.26M |
| March 31, 2022 | 480.08M |
| December 31, 2021 | 517.96M |
| September 30, 2021 | 543.44M |
| June 30, 2021 | 567.49M |
| March 31, 2021 | 603.87M |
| December 31, 2020 | 633.32M |
| Date | Value |
|---|---|
| September 30, 2020 | 325.41M |
| June 30, 2020 | 338.87M |
| March 31, 2020 | 216.94M |
| December 31, 2019 | 236.89M |
| September 30, 2019 | 250.13M |
| June 30, 2019 | 261.41M |
| March 31, 2019 | 165.52M |
| December 31, 2018 | 178.98M |
| September 30, 2018 | 187.42M |
| June 30, 2018 | 125.88M |
| March 31, 2018 | 138.20M |
| December 31, 2017 | 93.14M |
| September 30, 2017 | 100.80M |
| June 30, 2017 | 53.24M |
| March 31, 2017 | 59.15M |
| December 31, 2016 | 67.79M |
| September 30, 2016 | 74.57M |
| June 30, 2016 | 80.09M |
| March 31, 2016 | 78.47M |
| December 31, 2015 | 85.75M |
| September 30, 2015 | 41.23M |
| June 30, 2015 | 45.93M |
| March 31, 2015 | 53.57M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 36.67M |
| Fortress Biotech, Inc. | 196.58M |
| Syndax Pharmaceuticals, Inc. | 547.86M |
| Spero Therapeutics, Inc. | 50.77M |
| Gossamer Bio, Inc. | 57.03M |